| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | -13.63% | Goldman Sachs | $140 → $160 | Maintains | Neutral |
| 11/09/2023 | 13.35% | Needham | $160 → $210 | Maintains | Buy |
| 11/09/2023 | 17.13% | Piper Sandler | $191 → $217 | Maintains | Overweight |
| 10/20/2023 | 3.1% | Piper Sandler | → $191 | Reiterates | Overweight → Overweight |
| 10/19/2023 | 1.48% | B of A Securities | → $188 | Reinstates | → Neutral |
| 10/13/2023 | 3.1% | Piper Sandler | $170 → $191 | Maintains | Overweight |
| 09/28/2023 | 5.26% | UBS | → $195 | Initiates Coverage On | → Buy |
| 08/28/2023 | — | Raymond James | Reinstates | → Market Perform | |
| 08/09/2023 | -13.63% | Needham | → $160 | Reiterates | Buy → Buy |
| 08/09/2023 | -8.24% | Piper Sandler | $167 → $170 | Maintains | Overweight |
| 06/21/2023 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 06/07/2023 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 05/17/2023 | -13.63% | Needham | → $160 | Reiterates | Buy → Buy |
| 05/11/2023 | -28.75% | Goldman Sachs | $109 → $132 | Maintains | Neutral |
| 05/10/2023 | -13.63% | Needham | $115 → $160 | Maintains | Buy |
| 05/10/2023 | -16.33% | JMP Securities | → $155 | Reiterates | → Outperform |
| 05/10/2023 | -28.75% | Goldman Sachs | $109 → $132 | Maintains | Neutral |
| 05/10/2023 | -18.49% | Raymond James | $117 → $151 | Maintains | Outperform |
| 05/10/2023 | -26.59% | Barclays | $131 → $136 | Maintains | Equal-Weight |
| 05/10/2023 | -9.86% | Piper Sandler | $127 → $167 | Maintains | Overweight |
| 04/14/2023 | -16.33% | JMP Securities | $128 → $155 | Maintains | Outperform |
| 04/13/2023 | -29.29% | Barclays | $99 → $131 | Maintains | Equal-Weight |
| 03/02/2023 | -41.16% | Goldman Sachs | $92 → $109 | Maintains | Neutral |
| 03/01/2023 | -46.56% | Barclays | $84 → $99 | Maintains | Equal-Weight |
| 03/01/2023 | -36.85% | Raymond James | $109 → $117 | Maintains | Outperform |
| 03/01/2023 | -37.93% | Needham | → $115 | Reiterates | → Buy |
| 03/01/2023 | -31.45% | Piper Sandler | $95 → $127 | Maintains | Overweight |
| 01/25/2023 | -54.66% | Barclays | $83 → $84 | Maintains | Equal-Weight |
| 01/03/2023 | -48.72% | Piper Sandler | $119 → $95 | Maintains | Overweight |
| 11/11/2022 | -43.32% | B of A Securities | $130 → $105 | Maintains | Buy |
| 11/11/2022 | -55.2% | Barclays | $102 → $83 | Maintains | Equal-Weight |
| 11/11/2022 | -41.16% | Raymond James | $111 → $109 | Maintains | Outperform |
| 08/05/2022 | -44.94% | Barclays | $95 → $102 | Maintains | Equal-Weight |
| 07/19/2022 | -48.72% | Barclays | $80 → $95 | Maintains | Equal-Weight |
| 07/11/2022 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 07/07/2022 | -37.93% | Needham | → $115 | Initiates Coverage On | → Buy |
| 06/24/2022 | -35.77% | Piper Sandler | $95 → $119 | Maintains | Overweight |
| 06/10/2022 | -54.66% | Goldman Sachs | $106 → $84 | Maintains | Neutral |
| 05/13/2022 | -27.13% | B of A Securities | $165 → $135 | Maintains | Buy |
| 05/13/2022 | -47.1% | Raymond James | → $98 | Upgrades | Market Perform → Outperform |
| 05/13/2022 | -48.72% | Piper Sandler | $111 → $95 | Maintains | Overweight |
| 03/21/2022 | -39.54% | Keybanc | → $112 | Upgrades | Sector Weight → Overweight |
| 03/04/2022 | -35.23% | Evercore ISI Group | $195 → $120 | Maintains | Outperform |
| 03/04/2022 | -40.08% | Piper Sandler | $137 → $111 | Maintains | Overweight |
| 01/13/2022 | -26.05% | Piper Sandler | $182 → $137 | Maintains | Overweight |
| 11/11/2021 | 5.26% | Evercore ISI Group | $140 → $195 | Upgrades | In-Line → Outperform |
| 11/11/2021 | -13.63% | Barclays | $125 → $160 | Maintains | Equal-Weight |
| 11/11/2021 | -1.76% | Piper Sandler | $156 → $182 | Maintains | Overweight |
| 11/03/2021 | -2.84% | JMP Securities | $160 → $180 | Maintains | Market Outperform |
| 08/30/2021 | -13.63% | B of A Securities | → $160 | Initiates Coverage On | → Buy |
| 08/23/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 08/23/2021 | — | Raymond James | Initiates Coverage On | → Market Perform | |
| 08/23/2021 | -13.63% | JMP Securities | → $160 | Initiates Coverage On | → Market Outperform |
| 08/23/2021 | -32.53% | Barclays | → $125 | Initiates Coverage On | → Equal-Weight |
| 08/23/2021 | -24.43% | Evercore ISI Group | → $140 | Initiates Coverage On | → In-Line |
| 08/23/2021 | -32.53% | Goldman Sachs | → $125 | Initiates Coverage On | → Neutral |
| 08/23/2021 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 08/23/2021 | -15.79% | Piper Sandler | → $156 | Initiates Coverage On | → Overweight |
What is the target price for Duolingo (DUOL)?
The latest price target for Duolingo (NASDAQ: DUOL) was reported by Goldman Sachs on November 9, 2023. The analyst firm set a price target for $160.00 expecting DUOL to fall to within 12 months (a possible -13.63% downside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Duolingo (DUOL)?
The latest analyst rating for Duolingo (NASDAQ: DUOL) was provided by Goldman Sachs, and Duolingo maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Duolingo (DUOL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Duolingo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Duolingo was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Duolingo (DUOL) correct?
While ratings are subjective and will change, the latest Duolingo (DUOL) rating was a maintained with a price target of $140.00 to $160.00. The current price Duolingo (DUOL) is trading at is $185.26, which is out of the analyst's predicted range.